MNK-010

· Mallinckrodt

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MNK-010, covering 2017-04-05 to 2017-04-05. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors [Phase 1]